Delivery Order SPE2DB22D2211-SPE2DB25FRVUR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Dupixent 300 mg/2 ml syringes, with a ceiling value of $10,375.34. This competitive, firm fixed-price delivery order is scheduled for completion by August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's extensive pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $6,837.84. This non-set-aside, firm fixed price delivery order is scheduled for completion by July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's ongoing pharmaceutical supply support to federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes valued at $12,767.10, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Dupixent 300 mg/2 mL syringes, with a contract ceiling value of $16,450.43. This firm fixed price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 26, 2025. The pharmaceutical product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dupixent 200 mg/1.14 ml syringes with a ceiling value of $3,486.88. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,970.25 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery transaction under AmerisourceBergen's existing pharmaceutical supply framework. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $11,387.84. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of August 4, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and constitutes a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Dupixent 300 mg/2 ml syringes valued at $16,110.90 under a firm fixed price arrangement. This non-competitive delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $14,369.52. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, demonstrating AmerisourceBergen's continued capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dupixent 300 mg/2 mL syringes valued at $4,991.39. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete purchase under AmerisourceBergen's existing contract vehicle with the DLA. AmerisourceBergen Drug Corp is a major...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRVURDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $1,709.46. This competitive, firm fixed-price delivery order is set to be completed by April 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical pharmaceutical distributor within the federal medical supply chain, specifically supporting military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a child contract under this prime indefinite delivery vehicle, the award enables the company to supply pharmaceutical products and medical supplies to support defense healthcare programs globally. The parent contract serves multiple federal customers, including the Defense Health Agency and U.S. Coast Guard, and positions AmerisourceBergen as a key vendor for the upcoming Pharmaceutical Prime Vendor Global Program Generation V initiative, which will involve multiple regional awards across several contractors.